Search results for “PRC2” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 109 patents, we discovered top 11 key players by total patent application. Mirati Therapeutics, Inc., Novartis AG, Fulcrum Therapeutics, Inc. are dominant in this area. They take 66.06% of the total patent filing.
Mirati Therapeutics, Inc.
California, United States
Patent: 31
Novartis AG
Basel-Stadt, Switzerland
Patent: 27
Fulcrum Therapeutics, Inc.
Massachusetts, United States
Patent: 14
Shanghai Blueray Biopharma Co.,Ltd.
China
Patent: 12
Suzhou Suling Biomedical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Sequenom, Inc.
California, United States
Patent: 2
The General Hospital Corp.
Massachusetts, United States
Patent: 2
HitGen, Inc.
Sichuan Sheng, China
Patent: 1
Epizyme, Inc.
Massachusetts, United States
Patent: 1
Qingyu Pharmaceutical R&D (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 106 patents applied in the last 5 years. We discover 21 most active companies in this area. The fast-growing Mirati Therapeutics, Inc., Novartis AG, Fulcrum Therapeutics, Inc. take 55.66% of patent filing during this period.
Mirati Therapeutics, Inc.
California, United States
Patent: 31
Novartis AG
Basel-Stadt, Switzerland
Patent: 14
Fulcrum Therapeutics, Inc.
Massachusetts, United States
Patent: 14
Shanghai Blueray Biopharma Co.,Ltd.
China
Patent: 12
Korea Research Institute of Bioscience & Biotechnlogy
South Korea
Patent: 4
The Walter & Eliza Hall Institute of Medical Research
New South Wales, Australia
Patent: 4
Korea Research Institute of Chemical Technology
South Korea
Patent: 4
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 3
Suzhou Suling Biomedical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
St. Jude Children's Research Hospital, Inc.
Tennessee, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 106 patents in last 5 years, we discover 19 new entrants. Mirati Therapeutics, Inc., Fulcrum Therapeutics, Inc., Shanghai Blueray Biopharma Co.,Ltd. are the most active new entrants in this area.
Mirati Therapeutics, Inc.
California, United States
Patent: 31
Fulcrum Therapeutics, Inc.
Massachusetts, United States
Patent: 14
Shanghai Blueray Biopharma Co.,Ltd.
China
Patent: 12
Korea Research Institute of Bioscience & Biotechnlogy
South Korea
Patent: 4
The Walter & Eliza Hall Institute of Medical Research
New South Wales, Australia
Patent: 4
Korea Research Institute of Chemical Technology
South Korea
Patent: 4
Suzhou Suling Biomedical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
St. Jude Children's Research Hospital, Inc.
Tennessee, United States
Patent: 2
West China Hospital of Sichuan University
China
Patent: 2
Texas A&M University
Texas, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 4 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, Texas A&M University, The Rockefeller University are dominant in this area. They take 70.59% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 4
Texas A&M University
Texas, United States
Patent: 2
The Rockefeller University
New York, United States
Patent: 1
Université d'Aix-Marseille
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: